Replies to post #3215 on Intellipharmaceutics International Inc. (IPCI)

[~MulaGreen~]

Gregque,Here is the Link for the $15M/$40M PAR Approval Pay and Royalties...

http://seekingalpha.com/article/1650482-intellipharmaceutics-primed-for-an-easy-double

A total of 9 ANDA have been filed. IPCI lead product candidate (at this time), is a generic of Focalin XR, is partnered with Par Pharmaceutical Inc. Par Pharmaceutical Inc. markets generic drugs and innovative proprietary pharmaceuticals for specialty markets. Under the agreement, Par is to pay IntelliPharmaCeutics 15 million dollars upon approval, and royalties that are expected to be around 40 million per year. This will bring the company into profitability

Have a great Day!!!